API and IP Newsletter
Contents DMF filed in the month of July 2022 General information Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission Instead of Drug Spending Caps, Medicare Should Try Value-Based Contracting Intellectual Property Cadila Healthcare Ltd. v. Cadila Pharmaceuticals DMF filed in the month of July 2022 We analyse DMF filings by Indian companies. We had not it for a while and in this week we analysed DMFs filed in the month of July. Total 77 DMFs were filed in July 2022 and as usual more than 50% of them were from Indian companies. We are not publishing all our observation for all DMFs but some of our comments are in Sidvim comments section in the table below. HOLDER SUBJECT SIDVIM comments MALLADI DRUGS AND PHARMACEUTICALS LTD TRANEXAMIC ACID This is an old compound. It controls bleeding. About 700 MT world-wide market and USD 50-70/Kg product. There are seven active DMFs, including three Indians. DR REDDYS LABORATORIES LTD TOFACITINIB CITRATE FDA approved To